Surgical Innovations Group PLC Director/PDMR Shareholding (8029E)
09 Julio 2021 - 8:29AM
UK Regulatory
TIDMSUN
RNS Number : 8029E
Surgical Innovations Group PLC
09 July 2021
9 July 2021
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
Director/PDMR Shareholding
The Company was notified that on 7 July 2021 Adam Power, Group
Development Director, transferred 3,437,500 of shares in Surgical
Innovations (the "Ordinary Shares") from the Power Discretionary
Trust into his own name at a price of 3.25 pence per Ordinary
Share.
Following this transaction, the Power Discretionary Trust does
not hold any Ordinary Shares and there is no change to the combined
beneficial holding of Adam Power in the Company which remains at
31,562,500 Ordinary Shares, representing approximately 3.39% of the
issued share capital of the Company.
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, Co Sec & GFC
Singer Capital Markets (Nominated Tel: 020 7496 3000
Adviser & Broker)
Aubrey Powell / Rachel Hayes/
Iqra Amin
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391
303
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Adam Power
----------------------------------- -----------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
a) Position/status Group Development Director
----------------------------------- -----------------------------------------------
b) Initial notification/ Initial Notification
Amendment
----------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
a) Name Surgical Innovations Group plc
----------------------------------- -----------------------------------------------
b) LEI 2138004GHGUH3HUZE156
----------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
------------------------------------------------------------------------------------
a) Description of the financial Ordinary shares of 1p
instrument, type of instrument
Identification code
GB0004016704
----------------------------------- -----------------------------------------------
b) Nature of the transactions Transfer of Ordinary Shares
----------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------------------------- --------------------- ---------------------
3.25 pence per share 3,437,500
---------------------------------------------------------------- ---------------------
d) Aggregated information
* Aggregated volume
n/a- single transaction
* Price
----------------------------------- -----------------------------------------------
e) Date of the transaction 7 July 2021
----------------------------------- -----------------------------------------------
f) Place of the transaction Off-market Transaction
----------------------------------- -----------------------------------------------
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part
re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive
against fully disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners, and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
The Group currently employs approximately 100 people across two
sites in the UK. Product design, engineering and manufacturing are
carried out at the SI site in Yorkshire. Commercial activities
including marketing, UK distribution and international sales and
marketing are based at Elemental Healthcare in Berkshire.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www sigroupplc com
www surginno com
www elementalhealthcare co.uk
To receive regular updates by email, please contact
si@walbrookpr.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBXGDRRDGDGBC
(END) Dow Jones Newswires
July 09, 2021 09:29 ET (13:29 GMT)
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Surgical Innovations (LSE:SUN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024